Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis.
United European Gastroenterol J. 2022 May 13. doi: 10.1002/ueg2.12236. Online ahead of print.
United European Gastroenterol J. 2022.
PMID: 35560533
Free article.